1. Medtech Insight

Market Intel: 3D Bioprinting Forges Ahead With Mini Human Heart, Human Tissue

Can Bioprinting Become The Future Alternative To Organ Donation?

 
• By Bob Kronemyer

The race continues to heat up in the bioprinting space over which players will first reach the finish line in gaining approval for tissue and organ replacements. Research organizations and companies worldwide are in various states of development for these milestones in regenerative medicine, ranging from bioprinting skin to a mini human heart. But regulatory hurdles and quality testing could be formidable.

Concept of bioprinting of tissues and organs on red background. Colorful vector illustration in flat style. - Vector

Three-dimensional (3D) bioprinting represents the future of medicine for organ and tissue replacements, according to Shahram Seyedin-Noor, founder and general partner of Civilization Ventures, a San Francisco, CA-based venture capital firm which has invested in the space.

“Although a lot of start-ups have come to market in the bioprinting space, we believe there is a big difference between the viable innovators that can operate at scale with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiology

More from Device Area